Conditions:  Advanced or Metastatic Solid Tumor;  Advanced or Metastatic Gastric or Gastroesophageal Cancer;  Myeloid or Lymphoid Neoplasms (MLN)
Intervention: Â Drug:Â Futibatinib
Sponsor:  Taiho Oncology, Inc.
**RECRUITING NOW**
Intervention: Â Drug:Â Futibatinib
Sponsor:  Taiho Oncology, Inc.
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
